Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian

NCT01219777 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cancer
Fallopian Tube Cancer

Interventions

DRUG: carboplatin
DRUG: Bevacizumab
DRUG: Paclitaxel

Sponsor

Ritu Salani

Collaborators

[object Object]